Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(485)
•••
Post by old_dogon Jan 21, 2021 8:17am
168 Views
Post# 32342833

Short report is out

Short report is outShorts are way up and I LOVE IT...yes I LOVE IT........I'll tell you why later...got to eat Brekkie first

Symbol Issue Name Shares Net Change Date
$VPT.V VENTRIPOINT DIAGNOSTICS LTD. 1,810,906 1,810,673 21 Jan 2021
$VPT.V VENTRIPOINT DIAGNOSTICS LTD. 233 -8,502 7 Jan 2021
$VPT.V VENTRIPOINT DIAGNOSTICS LTD. 8,735 -761,111 21 Dec 2020
$VPT.V VENTRIPOINT DIAGNOSTICS LTD. 769,846 744,846 4 Dec 2020
$VPT.V VENTRIPOINT DIAGNOSTICS LTD. 25,000 -321,057 20 Nov 2020
$VPT.V VENTRIPOINT DIAGNOSTICS LTD. 346,057 213,303 6 Nov 2020
$VPT.V VENTRIPOINT DIAGNOSTICS LTD. 132,754 -469,573 21 Oct 2020
$VPT.V VENTRIPOINT DIAGNOSTICS LTD. 602,327 585,590 6 Oct 2020
$VPT.V VENTRIPOINT DIAGNOSTICS LTD. 16,737 0 21 Sep 2020
$VPT.V VENTRIPOINT DIAGNOSTICS LTD. 16,737 0 4 Sep 2020

old_dog
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities